Renée M. Y. Barge

2.1k total citations
44 papers, 1.5k citations indexed

About

Renée M. Y. Barge is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Renée M. Y. Barge has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 11 papers in Immunology and 9 papers in Genetics. Recurrent topics in Renée M. Y. Barge's work include Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Renée M. Y. Barge is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Renée M. Y. Barge collaborates with scholars based in Netherlands, United States and Belgium. Renée M. Y. Barge's co-authors include Roel Willemze, J.H. Frederik Falkenburg, Inge Jedema, Cornelis J. van Rooden, Menno V. Huisman, Frits R. Rosendaal, F.J.M. van der Meer, M. Willy Honders, Emile F. Schippers and Nicole M. van der Werff and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Renée M. Y. Barge

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renée M. Y. Barge Netherlands 23 504 379 343 318 214 44 1.5k
Edward Greeno United States 19 232 0.5× 205 0.5× 491 1.4× 146 0.5× 69 0.3× 40 1.3k
Laura L. Swystun Canada 20 815 1.6× 454 1.2× 173 0.5× 659 2.1× 22 0.1× 47 2.0k
D. Maroeska W. M. te Loo Netherlands 22 209 0.4× 297 0.8× 219 0.6× 310 1.0× 25 0.1× 73 1.5k
Moshe E. Gatt Israel 19 447 0.9× 630 1.7× 433 1.3× 174 0.5× 14 0.1× 113 1.3k
Jacob Nusbacher United States 22 483 1.0× 159 0.4× 110 0.3× 276 0.9× 28 0.1× 48 1.2k
Susumu Yasuoka Japan 20 198 0.4× 195 0.5× 113 0.3× 220 0.7× 37 0.2× 55 1.1k
MA Blajchman Canada 17 832 1.7× 171 0.5× 176 0.5× 135 0.4× 12 0.1× 38 1.6k
Chris Arthur Australia 16 1.5k 3.0× 154 0.4× 227 0.7× 71 0.2× 31 0.1× 34 1.9k
Ulf‐Henrik Mellqvist Sweden 24 1.4k 2.8× 739 1.9× 664 1.9× 486 1.5× 10 0.0× 60 2.2k
Grace M. Thomas United States 12 475 0.9× 519 1.4× 160 0.5× 970 3.1× 9 0.0× 24 1.8k

Countries citing papers authored by Renée M. Y. Barge

Since Specialization
Citations

This map shows the geographic impact of Renée M. Y. Barge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renée M. Y. Barge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renée M. Y. Barge more than expected).

Fields of papers citing papers by Renée M. Y. Barge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renée M. Y. Barge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renée M. Y. Barge. The network helps show where Renée M. Y. Barge may publish in the future.

Co-authorship network of co-authors of Renée M. Y. Barge

This figure shows the co-authorship network connecting the top 25 collaborators of Renée M. Y. Barge. A scholar is included among the top collaborators of Renée M. Y. Barge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renée M. Y. Barge. Renée M. Y. Barge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rooden, Cornelis J. van, Emile F. Schippers, H. F. L. Guiot, et al.. (2008). Prevention of Coagulase-Negative Staphylococcal Central Venous Catheter–Related Infection Using Urokinase Rinses: A Randomized Double-Blind Controlled Trial in Patients With Hematologic Malignancies. Journal of Clinical Oncology. 26(3). 428–433. 40 indexed citations
2.
Kempen-Harteveld, M. Loes van, Ronald Brand, Henk B. Kal, et al.. (2008). Results of Hematopoietic Stem Cell Transplantation After Treatment With Different High-Dose Total-Body Irradiation Regimens in Five Dutch Centers. International Journal of Radiation Oncology*Biology*Physics. 71(5). 1444–1454. 10 indexed citations
3.
Harder, Helena, Arthur R. Van Gool, Hugo J. Duivenvoorden, et al.. (2007). Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: Two-year follow-up results. European Journal of Cancer. 43(14). 2052–2059. 22 indexed citations
4.
Kalpoe, Jayant, Pim L. J. van der Heiden, Norbert Vaessen, et al.. (2007). Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning. Bone Marrow Transplantation. 40(2). 137–143. 14 indexed citations
5.
Kalpoe, Jayant, Pim L. J. van der Heiden, Renée M. Y. Barge, et al.. (2007). Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. European Journal Of Haematology. 78(4). 314–321. 37 indexed citations
6.
Hove, W. Rogier ten, Hein W. Verspaget, Renée M. Y. Barge, C. B. H. W. Lamers, & Bart van Hoek. (2007). Liver Chimerism After Allogeneic Blood Stem Cell Transplantation. Transplantation Proceedings. 39(1). 231–236. 9 indexed citations
7.
Vries, Jeltje F. de, Linda J. Wammes, Inge Jedema, et al.. (2006). Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria. APOPTOSIS. 12(1). 181–193. 19 indexed citations
8.
Walraven, Suzanna M. van, Martin B.A. Heemskerk, Renée M. Y. Barge, et al.. (2005). The importance of identifying a back-up donor for unrelated stem cell transplantation. Bone Marrow Transplantation. 35(5). 437–440. 10 indexed citations
10.
Bezrookove, Vladimir, Shama L. van Zelderen‐Bhola, Antoinette A. T. P. Brink, et al.. (2004). A novel t(6;14)(q25∼q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Cancer Genetics and Cytogenetics. 149(1). 72–76. 28 indexed citations
11.
Brand, R., Anja van Biezen, Renée M. Y. Barge, et al.. (2003). Allogeneic stem cell transplantation with matched related and unrelated donors for patients with refractory anemia: T-cell depletion and reduced intensity regimens are associated with increased relapse risk. Blood. 102(11). 1 indexed citations
12.
Jedema, Inge, Renée M. Y. Barge, Roel Willemze, & JH Falkenburg. (2003). High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment. Leukemia. 17(3). 576–584. 25 indexed citations
13.
Honders, M. Willy, et al.. (2003). Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines. Leukemia Research. 27(5). 445–453. 15 indexed citations
14.
Lokhorst, Henk M., Christine M. Segeren, Leo F. Verdonck, et al.. (2003). Partially T-Cell–Depleted Allogeneic Stem-Cell Transplantation for First-Line Treatment of Multiple Myeloma: A Prospective Evaluation of Patients Treated in the Phase III Study HOVON 24 MM. Journal of Clinical Oncology. 21(9). 1728–1733. 59 indexed citations
15.
Jedema, Inge, Renée M. Y. Barge, Vincent H. J. van der Velden, et al.. (2003). Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity. Leukemia. 18(2). 316–325. 111 indexed citations
16.
Honders, M. Willy, et al.. (2002). Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia. European Journal Of Haematology. 69(3). 171–178. 25 indexed citations
17.
Kruize, Aike A., F.H.J. van den Hoogen, WE Fibbe, et al.. (2001). High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: Results of an open study to assess feasibility, safety, and efficacy. Arthritis & Rheumatism. 44(4). 754–760. 77 indexed citations
18.
Brouwer, Rolf E., Juliette J. Hoefnagel, Inge Jedema, et al.. (2001). Expression of co‐stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis. British Journal of Haematology. 115(2). 298–308. 34 indexed citations
19.
Honders, M. Willy, et al.. (2000). High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia. Blood. 96(4). 1517–1524. 5 indexed citations
20.
Barge, Renée M. Y., Roel Willemze, Peter Vandenabeele, Walter Fiers, & Rudi Beyaert. (1997). Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal. FEBS Letters. 409(2). 207–210. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026